- Australian health authorities have recommended against a fifth COVID-19 vaccine shot despite average daily cases having been 47% higher last week than the week before, said Health Minister Mark Butler at a press conference.
- The authorities have urged eligible to sign up for their remaining booster doses amid growing cases, but remain 85% below the previous peak of late July.
- Butler said the Australian Technical Advisory Group on Immunizations (ATAGI) had recommended against a fifth dose or the third booster, Reuters reported.
- The recommendation follows evidence from Singapore's recent wave showed that severe illness and death were rare among the vaccinated and that a fifth shot had minimal impact on virus transmission.
- Related: Moderna Says Omicron Tailored COVID-19 Shots Shows Better Immune Response Than Original Vaccine.
- "ATAGI has considered international evidence as well as the local data around vaccination numbers and case numbers in the pandemic and decided not to recommend the fifth dose," said Butler.
- "They noted that severe disease and death during that wave in Singapore was very rare for people who had had at least two doses of vaccine for COVID."
- New booster recommendations will be made early next year ahead of the southern-hemisphere winter.
- Butler also accepted ATAGI recommendations that Pfizer Inc's PFE omicron-specific vaccine be approved as a booster dose for adults; 4.7 million doses will arrive ahead of a rollout due to begin on December 12.
- The company's vaccine for children aged six months to five years will also be approved for use on the severely immunocompromised.
- Photo by Daniel Schludi on Unsplash
Loading...
Loading...
AZNAstraZeneca PLC
$78.791.09%
Edge Rankings
Momentum
34.72
Growth
70.58
Quality
64.35
Value
22.19
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.